Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1-G93A transgenic mice

  1. Gento-Caro, Á.
  2. Vilches-Herrando, E.
  3. García-Morales, V.
  4. Portillo, F.
  5. Rodríguez-Bey, G.
  6. González-Forero, D.
  7. Moreno-López, B.
Journal:
Neuropathology and Applied Neurobiology

ISSN: 1365-2990

Year of publication: 2021

Volume: 47

Issue: 7

Pages: 1004-1018

Type: Article

DOI: 10.1111/NAN.12699 GOOGLE SCHOLAR
Data source: Scopus